ICLR Live signals | Maximize Profits with Getagraph.com

SELL 3442 min ago

@ $324.88

Issued: 31 May 2024 @ 15:54

Return: -0.02%

Previous signal: May 31 - 15:04

Previous signal: Buy

Return: 1.00 %

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):
Our systems believe the stock currently is overvalued by 0.76% compare to its pairs and should correct downwards.

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally...

Stats
Today's Volume	655 951
Average Volume	515 682
Market Cap	26.86B
EPS	$0 ( 2024-04-26 )
Next earnings date	( $3.62 ) 2024-07-24
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	39.37
ATR14	$9.50 (2.92%)

Correlation (AI algo v.1.1b): Overvalued: -0.76% $322.38 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.23 (neutral)

Short: -0.33 (neutral)

Signal:(74) Neutral

ICON PLC Correlation

10 Most Positive Correlations
CLBT	0.929
VEON	0.928
PEGA	0.921
AIHS	0.917
EQ	0.91
ALRM	0.908
ICFI	0.904
MEDP	0.904
BCYC	0.902
POWL	0.9

10 Most Negative Correlations
SSRM	-0.899
SABR	-0.893
CYAN	-0.893
FINW	-0.88
WTER	-0.878
ALNY	-0.861
BIOL	-0.858
GMBLP	-0.85
PBHC	-0.847
DSWL	-0.847

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ICON PLC Correlation - Currency/Commodity

0.14
( neutral )

0.04
( neutral )

-0.19
( neutral )

-0.07
( neutral )

0.19
( neutral )

ICON PLC Financials

Annual	2023
Revenue:	$8.12B
Gross Profit:	$1.81B (22.34 %)
EPS:	$7.46

FY	2023
Revenue:	$8.12B
Gross Profit:	$1.81B (22.34 %)
EPS:	$7.46

FY	2022
Revenue:	$7.74B
Gross Profit:	$2.21B (28.60 %)
EPS:	$6.20

FY	2021
Revenue:	$5.48B
Gross Profit:	$1.51B (27.52 %)
EPS:	$2.28

Financial Reports:

No articles found.

ICON PLC Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

ICON PLC

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.